FDA indicators instruction when GH is accepted; off-label use calls for stable proof, cautious monitoring

https://www.protopage.com/connetngrz#Bookmarks

FDA signals guideline while GH is authorized; off-label use requires effective evidence, cautious monitoring, and obvious consent discussions.